Security key
59935V107
Milestone Pharmaceuticals Inc. - Common Shares, no par value per share (MIST)
CUSIP: 59935V107
Q4 2021 13F Holders as of 31 Dec 2021
- Security type / class
- Equity / Common Shares, no par value per share
- Total 13F shares
- 20,243,658
- Total 13F value
- $132,596,706
- Share change
- +272,907
- SEC-reported price per share
- $6.55
- Number of holders
- 27
- Value change
- +$1,818,999
- Number of buys
- 12
- Number of sells
- 7
- Shares outstanding
- 124,817,707
Holder snapshot
6 signals
Security identity
Who this page is about.
1 source field
Report period
Q4 2021
Institutions
27
Top holders
10
MIST full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2022
Previous quarter: Q3 2021
Milestone Pharmaceuticals Inc. SEC filings
Milestone Pharmaceuticals Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 59935V107
Recent filing periods:
Ownership snapshot
Top reported holders of MIST - Milestone Pharmaceuticals Inc. - Common Shares, no par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
RTW INVESTMENTS, LP
Disclosed value leader
RTW INVESTMENTS, LP
Comparable rows
15/15
Latest evidence
30 Sep 2021
13F
Lead comparable stake: 3.5%
Showing 1-6 of 15 holder rows.
Quick read
RTW INVESTMENTS, LP leads the comparable SEC ownership view at 3.5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens RTW INVESTMENTS, LP's linked filing trail.
Comparable ownership
Top 5
RTW INVESTMENTS, LP
3.5%
ORBIMED ADVISORS LLC
2.1%
Boxer Capital, LLC
2.1%
Novo Holdings A/S
2%
RA CAPITAL MANAGEMENT, L.P.
1.8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13F
Company
|
3.5%
|
$24,639,000
4,315,102 shares
|
— | 30 Sep 2021 |
| ORBIMED ADVISORS LLC |
13F
Company
|
2.1%
|
$14,754,000
2,583,821 shares
|
— | 30 Sep 2021 |
| Boxer Capital, LLC |
13F
Company
|
2.1%
|
$14,687,000
2,572,194 shares
|
— | 30 Sep 2021 |
| Novo Holdings A/S |
13F
Company
|
2%
|
$14,450,000
2,530,585 shares
|
— | 30 Sep 2021 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
1.8%
|
$12,828,000
2,246,503 shares
|
— | 30 Sep 2021 |
| Ikarian Capital, LLC |
13F
Company
|
1.4%
|
$9,993,000
1,750,043 shares
|
— | 30 Sep 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
27
Shares
20,243,658
Rows available
27
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
26
Q4 2021 holders
27
Holder diff
1
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 value | Q4 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend